-
venBio is a life sciences investment firm that partners with industry leaders to build game-changing medicines and technologies, with a focus on novel therapeutics for unmet medical needs.
Latest News
-
2020
30JUNAkero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients
posted by admin in Latest NewsAkero Announces Strongly Positive Histological Data Across All Efruxifermin Dose Groups in 16-Week Phase 2a BALANCED Study in NASH Patients...
Read More -
2020
26JUNArtiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer
posted by admin in Latest NewsArtiva Biotherapeutics Launches with $78 Million Series A Financing to Advance NK Cell Therapies to Treat Cancer...
Read More -
2020
10JUNCheckmate Pharmaceuticals Secures $85 Million in Series C Financing
posted by admin in Latest NewsCheckmate Pharmaceuticals Secures $85 Million in Series C Financing...
Read More -
2020
09JUNNFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis
posted by admin in Latest NewsNFlection Therapeutics Launches with $20M Series A Funding to Advance Lead Program in Neurofibromatosis...
Read More